Peripheral Arterial Disease Trial, Recruiting NCT06887101 Sponsor: University Hospital, Essen Condition: Peripheral Arterial Disease
Back to Peripheral Arterial Disease

Peripheral Arterial Disease Trial, Recruiting

NCT06887101
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • You have been diagnosed with peripheral artery disease (poor blood flow in the legs) and have had a bypass surgery on a leg artery
  • You have had a bypass surgery involving the large artery in your abdomen (aorta) connecting to the leg arteries
  • You have had a procedure to open up a blocked or narrowed artery in your pelvis or leg using a small balloon (angioplasty)
  • You have had a leg or foot amputation due to problems with blood flow in your arteries
  • You experience leg pain when walking (intermittent claudication) AND have either a low ankle-to-arm blood pressure ratio (below 0.90) or a narrowing of a leg artery of 50% or more, confirmed by a scan or imaging test
  • You have had a procedure to clear or bypass a blocked artery in your neck (carotid artery)
  • You have a narrowing of 50% or more in a neck artery (carotid artery) that has been confirmed by a scan, even if you have no symptoms

Who may not be able to join:

  • You have a heart rhythm condition called atrial fibrillation (an irregular, often fast heartbeat)
  • You have a high number of irregular extra heartbeats coming from the lower chambers of your heart (confirm with trial site)
  • You have a pacemaker that continuously controls your heart's lower chambers
  • You are taking certain heart rhythm medications known as Class I or Class III antiarrhythmic drugs (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 20 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +49201723-84995

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
University Hospital, Essen
Registry
ClinicalTrials.gov
Start date
21 April 2023
Est. completion
31 December 2025

Where this trial is recruiting

🇩🇪 Germany

Primary endpoints

Occurrence of Myocardial Infarction (MI), Ischemic Stroke, Acute Limb Ischemia (ALI), Coronary Heart Disease (CHD) Death, or chronic limb ischemia and amputation; Pychological stress; Heart rate variability (HRV); Proinflammatory mediators - IL-6; Proinflammatory mediators - IL-1ß; Proinflammatory mediators - TNFalpha; Proinflammatory mediators - hsCRP; Hair cortisol concentration

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 20 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov